Retatrutide

Retatrutide is a next-generation synthetic peptide designed for advanced preclinical research. As a triple incretin receptor agonist, it simultaneously targets GLP-1R, GIPR, and glucagon receptors, making it one of the most mechanistically complex compounds available for metabolic signalling research in 2026.

Available in 10mg, 15mg, 20mg and 30mg vials. Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.

Research applications include:

• Multi-receptor agonism studies (GLP-1R / GIPR / Glucagon receptor)
• Metabolic and energy homeostasis pathway modelling
• Comparative receptor engagement vs single and dual agonist compounds
• Gut-brain axis and appetite regulation research

Product specifications:

• Form: Lyophilised powder
• Purity: ≥99% (HPLC verified)
• Storage: −20°C, protected from light and moisture
• Available sizes: 10mg · 15mg · 20mg · 30mg
• Origin: UK warehouse, same day dispatch